MENU
SERA
AS OF
Feb 3, 04:56 PM (EDT)
Price
$2.82
Change
-$0.38 (-11.88%)
Capitalization
107.29M
50 days until earnings call
Intraday BUY SELL Signals
+Compare
SERA
Stock ticker: NASDAQ
AS OF
Feb 3, 04:56 PM (EDT)
Price
$2.82
Change
-$0.38 (-11.88%)
Capitalization
107.29M

SERA Sera Prognostics Forecast, Technical & Fundamental Analysis

Sera Prognostics Inc is a health diagnostic company... Show more

SERA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SERA with price predictions
Feb 02, 2026

SERA in -4.17% downward trend, declining for three consecutive days on January 30, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SERA declined for three days, in of 276 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SERA as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SERA turned negative on January 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

SERA moved below its 50-day moving average on January 23, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SERA crossed bearishly below the 50-day moving average on January 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SERA advanced for three days, in of 199 cases, the price rose further within the following month. The odds of a continued upward trend are .

SERA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SERA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.305) is normal, around the industry mean (11.589). P/E Ratio (0.000) is within average values for comparable stocks, (38.571). SERA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.647). SERA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). SERA's P/S Ratio (1250.000) is very high in comparison to the industry average of (38.367).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SERA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
SERA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

SERA is expected to report earnings to rise 17.94% to -18 cents per share on March 25

Sera Prognostics SERA Stock Earnings Reports
Q4'25
Est.
$-0.19
Q3'25
Beat
by $0.07
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.01
The last earnings report on November 13 showed earnings per share of -15 cents, beating the estimate of -23 cents. With 7.83K shares outstanding, the current market capitalization sits at 107.29M.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
2749 East Parleys Way
Phone
+1 801 990-0520
Employees
57
Web
https://www.seraprognostics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYYNF0.220.07
+46.67%
Cynata Therapeutics Ltd.
TEMPF1.780.13
+7.88%
Persol Holdings Co Ltd
KNRRY29.530.47
+1.61%
Knorr-Bremse
LUVU0.03N/A
N/A
Luvu Brands, Inc.
OBSJF0.47N/A
N/A
Obrascon Huarte Lain Brasil S.A.

SERA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SERA has been loosely correlated with AMIX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SERA jumps, then AMIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SERA
1D Price
Change %
SERA100%
+0.72%
AMIX - SERA
41%
Loosely correlated
+1.71%
VAPO - SERA
41%
Loosely correlated
N/A
UTMD - SERA
29%
Poorly correlated
+1.15%
CORBF - SERA
27%
Poorly correlated
N/A
NNOX - SERA
26%
Poorly correlated
-0.37%
More

Groups containing SERA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SERA
1D Price
Change %
SERA100%
+0.72%
Medical/Nursing Services
industry (216 stocks)
1%
Poorly correlated
-0.81%
Health Services
industry (410 stocks)
-2%
Poorly correlated
-0.91%